EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antibody-Dependent Enhancement in Flavivirus Infections: From Fc Receptor Signaling to Vaccine and Therapeutic Design

Yiling Li, Zonghui Wu, Yingchao Cha, Wei Pang iD, Le Sun iD

Viruses · 20.08.2026 · 18 (8) · 916

DOI: 10.3390/v18080916 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 20.08.2026. Verfasst von Yiling Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Provincial Key Laboratory of Public Health and Biosafety, Department of Pathogen Biology and Immunology, School of Basic Medicine, Kunming Med…. Hauptthemen laut MEDLINE: Flavivirus Infections, Antibody-Dependent Enhancement, Flavivirus, Receptors, Fc. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Yunnan Talent Support Plant, Yunnan Province Science and Technology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infections caused by flaviviruses, including dengue virus (DENV), Zika virus (ZIKV), and West Nile virus (WNV), can lead to severe hemorrhagic or neurological disease. Antibody-dependent enhancement (ADE) remains a major obstacle to the development of safe flavivirus vaccines and antibody-based therapeutics. ADE includes ADE of infection, in which antibodies increase in viral entry, replication, or infection load, and ADE of disease, in which antibody-dependent inflammatory and immunopathological responses exacerbate disease severity. Previous reviews have largely addressed the general virological and immunological mechanisms of ADE, but few have integrated antibody isotypes and subclasses, Fc-region modifications, Fc receptor diversity, host FcγR polymorphisms, and complement activation within a translational framework. Consequently, how these factors jointly shape ADE of infection, progression to ADE of disease, and individual risk remains incompletely understood. Here, we synthesize evidence linking antibody properties, Fc receptor expression and signaling, FcγR genetic variation, and complement regulation to both forms of ADE. We then discuss how these findings can inform antigen selection, Fc engineering, complement-informed intervention, and systems serology-based risk stratification. By connecting mechanistic evidence with vaccine and therapeutic development, this review offers a framework for designing safer flavivirus interventions and advancing individualized assessment of ADE risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Flavivirus InfectionsAntibody-Dependent EnhancementFlavivirusReceptors, FcViral VaccinesAntibodies, ViralHumansAnimalsSignal TransductionReceptors, IgG

Stichwörter der Autor:innen

Fc receptorantibody-dependent enhancement (ADE)flavivirus

Substanzen

Receptors, FcViral VaccinesAntibodies, ViralReceptors, IgG

Autor:innen und Institutionen

  • Yunnan Provincial Key Laboratory of Public Health and Biosafety, Department of Pathogen Biology and Immunology, School of Basic Medicine, Kunming Medical University, Kunming 650500, China.
  • Yunnan Provencial Key Laboratory of Cross-Border Infectious Diseases Control & Drug Innovation, Department of Pathogen Biology and Immunology, School of Basic Medicine, Kunming Medical University, Kunming 650500, China.

ORCID-Profile: Wei Pang, Le Sun

Förderung

  • National Natural Science Foundation of China
  • Yunnan Talent Support Plant
  • Yunnan Province Science and Technology Department
  • Open Research fund of Yunnan Provencial Key Laboratory of Cross-border Infectious Diseases Control & Drug Innovation, grant number
  • First-Class Discipline Team of Kunming Medical University
  • Yunnan Key Research and Development Program
  • Yunnan Provencial Key Laboratory of Cross-border Infectious Diseases Control & Drug Innovation

Zitieren

APA

Li, Y., Wu, Z., Cha, Y., Pang, W., & Sun, L. (2026). Antibody-Dependent Enhancement in Flavivirus Infections: From Fc Receptor Signaling to Vaccine and Therapeutic Design. Viruses, 18(8), 916. https://doi.org/10.3390/v18080916

Vancouver

Li Y, Wu Z, Cha Y, Pang W, Sun L. Antibody-Dependent Enhancement in Flavivirus Infections: From Fc Receptor Signaling to Vaccine and Therapeutic Design. Viruses. 2026;18(8):916. doi:10.3390/v18080916

BibTeX
@article{Li2026,
  author = {Li, Yiling and Wu, Zonghui and Cha, Yingchao and Pang, Wei and Sun, Le},
  title = {Antibody-Dependent Enhancement in Flavivirus Infections: From Fc Receptor Signaling to Vaccine and Therapeutic Design},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {8},
  pages = {916},
  doi = {10.3390/v18080916}
}
Kostenlos starten →